Military / INH knows by now that Brilacidin is a power-packed antiviral. Once they get it into a nasal delivery form and it is ready for a major clinical trial what will they do if IPIX says they don't currently have the funds to run such a trial?

They can't leave it sitting on the shelf like they have done w/ Kevetrin for the last 7 or 8 years (needing only a bit more work and a pittance of money when looked at the big picture) to be in a pill delivery form or would they?

They handed BP billions upon billions for Covid development but we are to believe they cannot scrape up a couple of hundred thousand dollars for a major clinical trial for either B or K or a few million for B-ABSSSI which would put in their arsenal an antibacterial that actually could handle the superbugs?

Makes one think we are in the Twilight Zone.

My view is based on nobody saying anything about financial help from them except for the nasal delivery assistance and the in vitro research. Maybe most think that is enough. I just think they need to push it thru for the sake of mankind against a horde of deadly viruses.